Diaceutics PLC (DXRX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.021x

Based on the latest financial reports, Diaceutics PLC (DXRX) has a cash flow conversion efficiency ratio of 0.021x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX800.00K ≈ $97.34 USD) by net assets (GBX37.24 Million ≈ $4.53K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Diaceutics PLC (DXRX) balance sheet quality index to measure how much of total assets are equity-financed.

Diaceutics PLC - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Diaceutics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Diaceutics PLC earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Diaceutics PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diaceutics PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SRx Health Solutions Inc. NYSE MKT:SRXH	18.676x
AGM Group Holdings Inc Class A NASDAQ:AGMH	-0.078x
Airesis SA SW:AIRE	0.045x
TELES Informationstechnologien AG XETRA:TLIK	N/A
Rainbow Polikarbonat Sanayi Ticaret AS IS:RNPOL	0.103x
Fitness Champs Holdings Limited Common Stock NASDAQ:FCHL	1.106x
Sienna Resources Inc V:SIE	-0.071x
Linkers Industries Limited Class A Ordinary Shares NASDAQ:LNKS	N/A

Annual Cash Flow Conversion Efficiency for Diaceutics PLC (2016–2024)

The table below shows the annual cash flow conversion efficiency of Diaceutics PLC from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see DXRX market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX39.86 Million ≈ $4.85K	GBX651.00K ≈ $79.21	0.016x	-49.19%
2023-12-31	GBX40.79 Million ≈ $4.96K	GBX1.31 Million ≈ $159.51	0.032x	-73.18%
2022-12-31	GBX42.51 Million ≈ $5.17K	GBX5.10 Million ≈ $620.04	0.120x	+754.82%
2021-12-31	GBX40.65 Million ≈ $4.95K	GBX570.00K ≈ $69.35	0.014x	+123.02%
2020-12-31	GBX40.24 Million ≈ $4.90K	GBX253.00K ≈ $30.78	0.006x	+120.19%
2019-12-31	GBX20.13 Million ≈ $2.45K	GBX-627.05K ≈ $-76.29	-0.031x	+91.42%
2018-12-31	GBX2.63 Million ≈ $319.93	GBX-954.04K ≈ $-116.08	-0.363x	-144.41%
2017-12-31	GBX1.88 Million ≈ $228.47	GBX1.53 Million ≈ $186.66	0.817x	+22.70%
2016-12-31	GBX1.01 Million ≈ $123.16	GBX674.01K ≈ $82.01	0.666x	--

About Diaceutics PLC

LSE:DXRX UK Health Information Services

Market Cap

$1.48 Million

GBX12.14 Billion GBX

Market Cap Rank

#30271 Global

#740 in UK

Share Price

GBX143.50

Change (1 day)

+5.13%

52-Week Range

GBX126.50 - GBX176.50

All Time High

GBX187.50